Sampre Nutritions Limited has disclosed to BSE that its Chairman and Managing Director Brahma Gurbani was featured in The Business Fame magazine edition highlighting leadership and industry perspectives. The company made this announcement on 2 February 2026 under Regulation 30 of SEBI (LODR) Regulations, 2015, emphasizing transparency and good corporate governance.

Regulatory Disclosure Details

The disclosure was made pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company referenced SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated 30 January 2026 in its communication to the stock exchange.

Magazine Recognition as Strategic Visionary 2026

The Business Fame magazine featured Brahma Gurbani with the title 'Strategic Visionary 2026' and the tagline "Crafting a legacy of excellence through vision and discipline." The magazine's editorial note described the special edition as celebrating leadership that shapes industries and inspires generations, opening 2026 with a story reflecting purposeful growth, resilience, and strategic thinking.

Managing Editor Rohit Chaturvedi noted that Gurbani represents "a rare blend of vision, discipline, and enterprise that continues to elevate the Indian confectionery industry onto a global stage." The feature highlights how long-term commitment builds institutions and purpose-led leadership creates enterprises that endure.

Leadership Journey and Industry Impact

The magazine feature chronicles Gurbani's transformation from operating a single hand-operated machine to building an internationally admired enterprise. As Founder, Chairman and Managing Director of the Gurbani Group, he has developed the business over four decades into a major supplier for multinational clients with world-class manufacturing systems.

Key Leadership Roles and Achievements:

• President of the Indian Confectionery Manufacturers Association with the longest association within the organization
• Built partnerships with multinational corporations including Procter and Gamble, Mondelez International, Dabur India, Himalaya Wellness, Cipla, Nestle, ITC, Reliance Consumer Products, Patanjali Foods, Perfetti Van Melle, DS Group, and Godrej Hershey's Nutrine
• Developed a workforce of more than 450 skilled professionals across locations
• Maintained a three-decade partnership with Mondelez International

Manufacturing Excellence and Global Recognition

The Gurbani Group's flagship enterprise Sampre Nutritions Ltd in Medchal holds early HACCP certification from BVQI and maintains Halal and FSSC 22000 Version VI certifications. The facility was selected by an international quality audit team from Procter and Gamble for manufacturing Vicks Cough Drops for the Japanese market, reflecting production mastery and compliance excellence at a global scale.

Corporate Governance and Transparency

Sampre Nutritions Limited emphasized that the magazine feature disclosure was made as a general announcement in the interest of transparency and good corporate governance. The company clarified that the enclosed document is purely informational in nature and should not be construed as a promotional communication.

The disclosure reflects the company's commitment to keeping stakeholders informed about developments that may be of interest, even when such communications are primarily recognition-based rather than business-operational in nature.

Sampre Nutritions Limited has successfully completed the allotment of equity shares following the conversion of Foreign Currency Convertible Bonds (FCCBs), marking a significant development in the company's capital structure. The board of directors approved this conversion at their meeting held on December 22, 2025.

FCCB Conversion Details

The company converted 13 FCCBs with a total principal value of $1.30 million (United States Dollar One million three hundred thousand). This conversion resulted from a notice received from an FCCB holder requesting the conversion of their bonds into equity shares.

Share Capital Impact

Following this allotment, the company's financial structure has been strengthened with an expanded equity base. The conversion has resulted in a substantial increase in the total number of outstanding shares.

Background and Timeline

Sampre Nutritions had originally allotted 100 FCCBs on June 28, 2024, as part of its fundraising initiative. The recent conversion represents a portion of these bonds being exercised by holders who opted to convert their debt instruments into equity participation.

The board meeting that approved this conversion commenced at 4:00 PM IST and concluded at 6:00 PM IST on December 22, 2025. The decision was made in accordance with the terms outlined in the Offering Memorandum that governed the FCCB issuance.

Regulatory Compliance

The allotment was conducted under Regulation 30 of the Securities and Exchange Board of India (SEBI) regulations, ensuring full compliance with disclosure requirements. The company has duly informed BSE Limited about this development, maintaining transparency with stakeholders and regulatory authorities.